Du är här


Medical Prognosis Institute: MPI - Summary of Extraordinary General Meeting

Hoersholm; Denmark February 9, 2016 - Today at 4 p.m., an extraordinary
general meeting was convened in Medical Prognosis Institute A/S with the
following agenda:

1 Resolution on the transfer of the Company's admittance to trading on Nasdaq
First North Denmark to Nasdaq First North Sweden
2 Any other business

In accordance with article 11.2 of the Company's articles of association, the
board of directors had appointed Attorney-at-Law Thomas Holst Laursen to
chair the general meeting.

Re item 1
The general meeting adopted the proposals of the board of directors.

Re item 2
There were no proposals for discussion under this item.

The board of directors of Medical Prognosis Institute A/S
Venlighedsvej 1, 2970 Hoersholm
Telephone: +45 22 93 08 37/+45 40 14 50 59

For further information, please contact

Peter Buhl Jensen, CEO
e-mail: pbj@medical-prognosis.com
Phone: +45 21 60 89 22

Certified Advisor:

Carsten Yde Hemme, PricewaterhouseCoopers, Strandvejen 44, 2900 Hellerup,

MPI - Summary of EGM


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Medical Prognosis Institute via Globenewswire


Författare WKR

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.